What is heartburn worth? A cost-utility analysis of management strategies - Wikidata - wikimedia - TriplyDB

What is heartburn worth? A cost-utility analysis of management strategies

What is heartburn worth? A cost-utility analysis of management strategies

http://www.wikidata.org/entity/Q34745082

about

Value-based medicine and ophthalmology: an appraisal of cost-utility analyses.The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.Value-based medicine: evidence-based medicine and beyond.Health Economics Information in Wound Care: The Elephant in the Room Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and Sweden.

P2860

Q31151282-66EA2F22-5E2D-4A56-BB9C-72E30A96C976 Q33329793-4DC7DFCD-0EDA-41A3-A28A-86B317ADD3CA Q34786709-1DB7DBF0-A634-4990-B6C5-1F51C67BD6D5 Q35563038-035FD062-995F-423B-A353-217427B7D5A9 Q37398186-925EE0C9-D2E2-4C9A-B967-4B0B121EC16C Q50740139-6CC65A4D-0D91-4ACE-BEB6-6CF4645906B4

P2860

What is heartburn worth? A cost-utility analysis of management strategies

http://www.wikidata.org/entity/Q34745082

description

2000 nî lūn-bûn

@nan

2000 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մարտին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

What is heartburn worth? A cost-utility analysis of management strategies

@ast

What is heartburn worth? A cost-utility analysis of management strategies

@en

What is heartburn worth? A cost-utility analysis of management strategies

@nl

type

label

What is heartburn worth? A cost-utility analysis of management strategies

@ast

What is heartburn worth? A cost-utility analysis of management strategies

@en

What is heartburn worth? A cost-utility analysis of management strategies

@nl

prefLabel

What is heartburn worth? A cost-utility analysis of management strategies

@ast

What is heartburn worth? A cost-utility analysis of management strategies

@en

What is heartburn worth? A cost-utility analysis of management strategies

@nl

P1433

Q34745082-3FD3B379-D8F6-4C01-B889-23122E86F76D

P1476

Q34745082-5F9F7432-CB26-4B1E-9A2B-FC93BDF03DB3

P2093

Q34745082-2119B1B0-B521-4EBC-AF18-53715E4B9B01

Q34745082-5EC1386B-B79B-47C6-BCFB-8C1F959F98CE

Q34745082-736B195B-B81E-4C74-BCAE-4BACE0AB9150

Q34745082-A22B1F3E-1305-414B-BC2E-D00845E7865C

Q34745082-B5AAC37C-0E8B-41B2-9CC3-2B2269A4F7D2

Q34745082-DD007AE2-0B4D-4E9B-9614-F889663A8CD3

P2860

Q34745082-03829A27-B7B2-46FC-BB14-0D93BDAEFEC6

Q34745082-06F46FE8-5C58-45EA-BB2F-D7B86D8DE690

Q34745082-081EED47-AE98-4276-96C5-47F681D8CD30

Q34745082-0CB51BF7-5157-4148-B1EF-BC7E000D1B2D

Q34745082-0D09A4B5-4C42-484E-8A2A-A9931FC74D35

Q34745082-1543314B-0AFA-48F8-A9A1-C7B25A179C1F

Q34745082-2293A1D4-C7DC-4F9A-80E0-74826F24C812

Q34745082-431A9EF2-DAE0-450F-BABC-6E85B4F3690D

Q34745082-44FA7440-611C-42A9-9AE9-946E29628A1D

Q34745082-457B86CD-42C0-4BD5-BF7A-37222D38C01A

P2888

Q34745082-6E3329E9-44DD-4DDA-8A58-8245B5EF3259

P304

Q34745082-FCE053B0-6203-41AD-8506-373A06C1B6F3

P31

Q34745082-A9AF85BF-EFDB-42DB-9F5C-536AC546CBA9

P356

Q34745082-F219BBBA-06E4-4D70-9728-196965790473

P433

Q34745082-F3F38366-FA7E-4A81-BE32-022DA4D2A7A8

P478

Q34745082-528120A4-2995-4F56-82B1-BE25A0C3241B

P577

Q34745082-BAC06E86-565B-4E18-8D9F-A2E2346B21BF

P5875

Q34745082-6FA411BF-BE83-4699-BA11-232CCB0B803A

P6179

Q34745082-99DA3785-1B06-4756-91F9-11EE228DAB84

P698

Q34745082-ADF65C18-F92F-4616-BE80-50B658E5B43D

P932

Q34745082-1C6E3775-1BCB-4ED8-AC2D-00EFBDEA6A93

P356

J.1525-1497.2000.02639.X

P1433

Journal of General Internal Medicine

P1476

What is heartburn worth? A cost-utility analysis of management strategies

@en

P2093

C M Wilcox

http://www.w3.org/2001/XMLSchema#string

G R Heudebert

http://www.w3.org/2001/XMLSchema#string

J C Klapow

http://www.w3.org/2001/XMLSchema#string

L Johnson

http://www.w3.org/2001/XMLSchema#string

R M Centor

http://www.w3.org/2001/XMLSchema#string

R Marks

http://www.w3.org/2001/XMLSchema#string

P2860

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.

Heartburn--the acid test.

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.

Heartburn requiring frequent antacid use may indicate significant illness.

Long-term management of gastroesophageal reflux disease and its complications.

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study.

P2888

j.1525-1497.2000.02639.x

P304

175-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1525-1497.2000.02639.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12596813

http://www.w3.org/2001/XMLSchema#string

P6179

1030229733

http://www.w3.org/2001/XMLSchema#string

P698

10718898

http://www.w3.org/2001/XMLSchema#string

P932

1495356

http://www.w3.org/2001/XMLSchema#string